Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Gyre Therapeutics, Inc. Common Stock

GYRE Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of GYRE by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
GYRE Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
GYRE Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
GYRE Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in GYRE holdings by institutional investors

Quarterly net insider trading by GYRE's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for GYRE

Quiver Logo

No former government officials on record as having lobbied for GYRE

Revolving Door Dashboard

GYRE Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

GYRE Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
GYRE Income Statement
GYRE Balance Sheet
GYRE Cash Flow
U.S. Patents

New GYRE patent grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to GYRE from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
GYRE News

Recent insights relating to GYRE

CNBC Recommendations

Recent picks made for GYRE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GYRE

GYRE Analyst Ratings

GYRE Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
GYRE Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $GYRE stock a Buy, Sell, or Hold?

  • What is the price target for $GYRE stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

GYRE Top Shareholders
Shareholder
Shares Held
GYRE Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $GYRE stock?

  • Who owns the most shares of $GYRE stock?

  • What funds own $GYRE stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

GYRE Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view GYRE Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About GYRE

Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

  • Address San Diego, CA
  • Market Cap 777.2 million
  • Employees 618
  • Industrial Classification Pharmaceutical Preparations

Gyre Therapeutics, Inc. Common Stock (GYRE) Historical Stock Prices

Gyre Therapeutics, Inc. Common Stock (GYRE) closed at $7.33 on September 24, 2026. Over the past year its adjusted close ranged from $5.56 to $8.87. Daily prices go back to August 21, 2015, 2,789 trading days in all.

  • 1 month+9.73%
  • 3 months+17.66%
  • Year to date+3.82%
  • 1 year-0.54%
  • 3 years+1,366.00%
  • 5 years+54.64%
  • Max-17.45%
See every congressional and insider trade on the GYRE price chart

Quiver Premium charts GYRE's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 7.40 7.44 6.81 7.33 7.33 327,689
Sep 23, 2026 7.49 7.50 7.04 7.40 7.40 164,558
Sep 22, 2026 7.40 7.61 7.26 7.49 7.49 227,129
Sep 21, 2026 7.55 7.57 7.21 7.43 7.43 364,869
Sep 18, 2026 7.12 7.56 7.10 7.55 7.55 1,203,860
Sep 17, 2026 6.80 7.20 6.80 7.18 7.18 143,912
Sep 16, 2026 6.70 6.86 6.59 6.70 6.70 126,369
Sep 15, 2026 6.69 6.72 6.46 6.69 6.69 97,766
Sep 14, 2026 6.82 7.04 6.68 6.69 6.69 104,123
Sep 11, 2026 6.86 6.95 6.73 6.73 6.73 69,803
Sep 10, 2026 6.93 6.96 6.74 6.74 6.74 83,103
Sep 9, 2026 7.17 7.26 6.94 6.95 6.95 104,720
Sep 8, 2026 6.85 7.20 6.85 7.17 7.17 240,884
Sep 4, 2026 6.44 6.89 6.41 6.86 6.86 56,023
Sep 3, 2026 6.37 6.54 6.36 6.44 6.44 41,205
Sep 2, 2026 6.41 6.67 6.34 6.36 6.36 58,066
Sep 1, 2026 6.51 6.57 6.32 6.47 6.47 54,547
Aug 31, 2026 6.60 6.64 6.43 6.57 6.57 41,714
Aug 28, 2026 6.70 6.70 6.54 6.59 6.59 43,162
Aug 27, 2026 6.63 6.77 6.63 6.68 6.68 25,344
Aug 26, 2026 6.71 6.81 6.60 6.65 6.65 38,820
Aug 25, 2026 6.53 6.72 6.49 6.68 6.68 44,549
Aug 24, 2026 6.89 6.89 6.42 6.44 6.44 53,275
Aug 21, 2026 7.08 7.12 6.86 6.91 6.91 65,999
Aug 20, 2026 7.15 7.29 6.77 7.02 7.02 55,088
Aug 19, 2026 7.06 7.27 7.03 7.15 7.15 87,802
Aug 18, 2026 6.73 7.00 6.72 6.98 6.98 49,593
Aug 17, 2026 6.62 6.83 6.55 6.81 6.81 47,650
Aug 14, 2026 6.55 6.73 6.47 6.68 6.68 52,735
Aug 13, 2026 6.70 6.77 6.44 6.54 6.54 48,968
Aug 12, 2026 6.68 6.99 6.62 6.66 6.66 94,545
Aug 11, 2026 6.76 6.92 6.58 6.64 6.64 50,219
Aug 10, 2026 6.67 6.80 6.31 6.72 6.72 53,246
Aug 7, 2026 6.41 6.69 6.28 6.67 6.67 68,093
Aug 6, 2026 6.28 6.51 6.21 6.40 6.40 49,091
Aug 5, 2026 6.19 6.27 6.10 6.23 6.23 35,251
Aug 4, 2026 6.11 6.46 6.11 6.15 6.15 63,211
Aug 3, 2026 5.80 6.12 5.80 6.11 6.11 53,655
Jul 31, 2026 5.85 5.88 5.62 5.75 5.75 48,381
Jul 30, 2026 5.72 5.95 5.72 5.81 5.81 45,638
Jul 29, 2026 5.91 6.02 5.62 5.64 5.64 66,082
Jul 28, 2026 6.13 6.16 5.91 5.99 5.99 31,879
Jul 27, 2026 6.01 6.27 6.01 6.13 6.13 43,078
Jul 24, 2026 6.03 6.07 5.90 5.94 5.94 33,768
Jul 23, 2026 5.87 6.04 5.86 6.01 6.01 38,257
Jul 22, 2026 6.03 6.10 5.85 5.94 5.94 86,301
Jul 21, 2026 5.89 6.14 5.87 6.06 6.06 35,872
Jul 20, 2026 6.08 6.21 5.82 5.88 5.88 52,766
Jul 17, 2026 6.25 6.40 6.05 6.05 6.05 73,972
Jul 16, 2026 6.55 6.59 6.32 6.42 6.42 33,722
Jul 15, 2026 6.35 6.61 6.35 6.56 6.56 40,507
Jul 14, 2026 6.33 6.51 6.20 6.34 6.34 80,233
Jul 13, 2026 6.49 6.52 6.30 6.34 6.34 65,845
Jul 10, 2026 6.88 6.88 6.50 6.52 6.52 67,004
Jul 9, 2026 6.80 6.94 6.69 6.86 6.86 61,025
Jul 8, 2026 6.88 6.98 6.67 6.86 6.86 112,658
Jul 7, 2026 7.32 7.32 6.91 7.01 7.01 106,079
Jul 6, 2026 7.34 7.47 7.05 7.26 7.26 133,218
Jul 2, 2026 6.60 7.36 6.55 7.34 7.34 101,749
Jul 1, 2026 6.58 6.59 6.45 6.52 6.52 82,564
Jun 30, 2026 6.47 6.75 6.34 6.59 6.59 61,487
Jun 29, 2026 6.40 6.50 6.16 6.45 6.45 80,189
Jun 26, 2026 6.28 6.49 6.23 6.29 6.29 854,112
Jun 25, 2026 6.44 6.58 6.18 6.23 6.23 73,360
Jun 24, 2026 6.14 6.69 6.14 6.48 6.48 134,430
Jun 23, 2026 6.13 6.25 6.10 6.13 6.13 53,330
Jun 22, 2026 6.20 6.34 6.09 6.13 6.13 75,757
Jun 18, 2026 6.14 6.35 6.07 6.25 6.25 85,722
Jun 17, 2026 5.84 6.13 5.84 6.08 6.08 66,354
Jun 16, 2026 5.82 5.93 5.74 5.82 5.82 75,447
Jun 15, 2026 5.95 6.09 5.81 5.86 5.86 57,131
Jun 12, 2026 6.05 6.06 5.90 5.93 5.93 81,592
Jun 11, 2026 5.97 6.21 5.95 6.06 6.06 75,111
Jun 10, 2026 6.05 6.34 5.95 5.95 5.95 71,007
Jun 9, 2026 6.05 6.19 5.93 6.13 6.13 92,637
Jun 8, 2026 6.29 6.34 5.95 6.05 6.05 76,626
Jun 5, 2026 6.20 6.66 6.13 6.29 6.29 137,894
Jun 4, 2026 5.71 6.29 5.71 6.19 6.19 133,671
Jun 3, 2026 5.56 5.72 5.50 5.69 5.69 72,500
Jun 2, 2026 5.80 5.89 5.44 5.56 5.56 120,716
Jun 1, 2026 5.86 6.02 5.80 5.81 5.81 125,474
May 29, 2026 5.74 5.98 5.74 5.91 5.91 107,722
May 28, 2026 5.92 5.93 5.67 5.74 5.74 96,255
May 27, 2026 5.93 6.03 5.88 5.92 5.92 80,399
May 26, 2026 6.10 6.16 5.87 5.94 5.94 125,949
May 22, 2026 6.22 6.26 6.01 6.06 6.06 86,972
May 21, 2026 6.04 6.22 5.97 6.18 6.18 97,441
May 20, 2026 6.26 6.29 6.01 6.04 6.04 95,331
May 19, 2026 6.40 6.55 6.24 6.26 6.26 92,693
May 18, 2026 6.60 6.70 6.31 6.44 6.44 75,609
May 15, 2026 6.87 6.92 6.55 6.55 6.55 94,305
May 14, 2026 7.24 7.37 6.74 7.00 7.00 213,266
May 13, 2026 7.37 7.43 7.23 7.28 7.28 35,191
May 12, 2026 7.03 7.37 7.03 7.30 7.30 50,362
May 11, 2026 7.40 7.45 7.05 7.09 7.09 59,914
May 8, 2026 7.21 7.47 7.20 7.47 7.47 52,901
May 7, 2026 7.90 7.90 7.03 7.07 7.07 167,834
May 6, 2026 7.88 8.09 7.73 8.04 8.04 131,565
May 5, 2026 8.02 8.05 7.68 7.78 7.78 61,027
May 4, 2026 7.78 8.05 7.73 7.92 7.92 74,016
May 1, 2026 7.68 7.89 7.45 7.80 7.80 77,264
Apr 30, 2026 7.41 7.70 7.41 7.68 7.68 54,471
Apr 29, 2026 7.70 7.70 7.30 7.35 7.35 47,525
Apr 28, 2026 7.64 7.76 7.63 7.67 7.67 44,380
Apr 27, 2026 7.47 7.65 7.47 7.63 7.63 32,135
Apr 24, 2026 7.43 7.65 7.34 7.44 7.44 32,192
Apr 23, 2026 7.73 7.82 7.36 7.44 7.44 46,638
Apr 22, 2026 7.92 7.92 7.72 7.73 7.73 34,311
Apr 21, 2026 8.00 8.09 7.86 7.87 7.87 68,833
Apr 20, 2026 8.10 8.10 7.86 7.94 7.94 50,626
Apr 17, 2026 8.00 8.20 7.97 8.10 8.10 89,959
Apr 16, 2026 8.00 8.00 7.81 7.90 7.90 35,327
Apr 15, 2026 7.88 8.05 7.85 8.02 8.02 62,413
Apr 14, 2026 7.75 7.92 7.75 7.84 7.84 36,498
Apr 13, 2026 7.37 7.71 7.31 7.69 7.69 49,899
Apr 10, 2026 7.26 7.41 7.19 7.39 7.39 47,005
Apr 9, 2026 7.03 7.25 7.03 7.24 7.24 34,198
Apr 8, 2026 7.30 7.43 7.04 7.09 7.09 93,177
Apr 7, 2026 7.08 7.15 6.95 7.12 7.12 80,204
Apr 6, 2026 7.11 7.25 7.11 7.12 7.12 78,232
Apr 2, 2026 7.04 7.18 6.91 7.12 7.12 63,540
Apr 1, 2026 7.06 7.27 7.06 7.23 7.23 68,747
Mar 31, 2026 6.91 7.08 6.90 6.97 6.97 97,641
Mar 30, 2026 6.86 6.91 6.77 6.84 6.84 104,347
Mar 27, 2026 7.05 7.17 6.78 6.78 6.78 158,666
Mar 26, 2026 7.01 7.28 7.01 7.04 7.04 91,541
Mar 25, 2026 7.11 7.34 7.10 7.18 7.18 100,636
Mar 24, 2026 7.00 7.24 6.91 6.94 6.94 117,356
Mar 23, 2026 6.90 7.29 6.89 7.04 7.04 152,226
Mar 20, 2026 6.78 7.03 6.58 6.72 6.72 224,787
Mar 19, 2026 6.98 7.03 6.76 6.80 6.80 201,676
Mar 18, 2026 7.60 7.60 7.00 7.01 7.01 190,434
Mar 17, 2026 7.66 7.98 7.65 7.65 7.65 96,725
Mar 16, 2026 7.66 7.66 7.28 7.50 7.50 165,264
Mar 13, 2026 7.98 8.01 7.55 7.55 7.55 138,332
Mar 12, 2026 7.84 8.28 7.47 7.80 7.80 203,139
Mar 11, 2026 8.10 8.37 8.09 8.33 8.33 83,344
Mar 10, 2026 8.28 8.51 8.07 8.12 8.12 114,965
Mar 9, 2026 7.83 8.30 7.71 8.16 8.16 156,469
Mar 6, 2026 8.23 8.47 7.57 7.71 7.71 219,419
Mar 5, 2026 8.69 9.14 7.73 7.83 7.83 323,479
Mar 4, 2026 8.07 8.48 8.02 8.28 8.28 100,514
Mar 3, 2026 8.78 8.79 7.83 7.90 7.90 135,121
Mar 2, 2026 8.19 8.98 8.16 8.76 8.76 183,669
Feb 27, 2026 8.49 8.65 8.22 8.24 8.24 80,999
Feb 26, 2026 8.53 8.79 8.40 8.52 8.52 96,962
Feb 25, 2026 8.50 8.95 8.50 8.65 8.65 116,028
Feb 24, 2026 8.27 8.65 8.27 8.40 8.40 72,044
Feb 23, 2026 8.35 8.60 8.07 8.15 8.15 61,989
Feb 20, 2026 8.39 8.62 8.20 8.28 8.28 75,560
Feb 19, 2026 8.21 8.49 8.20 8.42 8.42 60,543
Feb 18, 2026 8.23 8.35 8.10 8.21 8.21 67,920
Feb 17, 2026 8.03 8.38 7.95 8.21 8.21 76,239
Feb 13, 2026 7.86 8.19 7.86 8.02 8.02 63,018
Feb 12, 2026 7.83 7.91 7.60 7.82 7.82 37,762
Feb 11, 2026 8.00 8.15 7.75 7.85 7.85 37,693
Feb 10, 2026 7.75 8.07 7.72 7.97 7.97 57,726
Feb 9, 2026 7.91 7.91 7.69 7.82 7.82 22,528
Feb 6, 2026 7.64 7.90 7.58 7.88 7.88 47,478
Feb 5, 2026 7.70 7.85 7.45 7.51 7.51 46,534
Feb 4, 2026 7.84 7.92 7.59 7.77 7.77 46,296
Feb 3, 2026 8.21 8.21 7.74 7.92 7.92 42,517
Feb 2, 2026 8.00 8.28 7.98 8.21 8.21 133,196
Jan 30, 2026 8.08 8.25 7.97 8.09 8.09 91,808
Jan 29, 2026 8.07 8.25 7.84 8.21 8.21 100,157
Jan 28, 2026 8.04 8.17 7.99 8.03 8.03 78,862
Jan 27, 2026 7.89 8.09 7.78 8.09 8.09 53,683
Jan 26, 2026 7.82 8.01 7.82 7.90 7.90 30,600
Jan 23, 2026 8.04 8.04 7.72 7.85 7.85 65,577
Jan 22, 2026 8.23 8.38 8.00 8.05 8.05 67,349
Jan 21, 2026 8.00 8.30 7.89 8.30 8.30 179,653
Jan 20, 2026 7.62 8.00 7.53 7.93 7.93 74,756
Jan 16, 2026 7.70 7.74 7.55 7.68 7.68 34,845
Jan 15, 2026 7.65 7.81 7.55 7.70 7.70 24,123
Jan 14, 2026 7.79 7.90 7.64 7.69 7.69 37,884
Jan 13, 2026 7.70 7.90 7.59 7.79 7.79 60,077
Jan 12, 2026 7.40 7.80 7.38 7.70 7.70 46,217
Jan 9, 2026 7.59 7.64 7.38 7.40 7.40 48,386
Jan 8, 2026 7.35 7.71 7.30 7.57 7.57 101,879
Jan 7, 2026 7.13 7.52 7.13 7.30 7.30 93,626
Jan 6, 2026 8.00 8.07 6.83 6.97 6.97 197,800
Jan 5, 2026 7.41 7.95 7.35 7.92 7.92 186,378
Jan 2, 2026 7.05 7.05 6.76 6.81 6.81 61,297
Dec 31, 2025 7.02 7.06 6.90 7.06 7.06 61,885
Dec 30, 2025 7.17 7.17 6.98 7.02 7.02 50,373
Dec 29, 2025 7.18 7.26 7.12 7.16 7.16 41,124
Dec 26, 2025 7.24 7.35 7.18 7.26 7.26 85,625
Dec 24, 2025 7.23 7.23 7.05 7.19 7.19 65,170
Dec 23, 2025 7.25 7.38 7.16 7.18 7.18 62,441
Dec 22, 2025 7.19 7.39 7.11 7.19 7.19 91,751
Dec 19, 2025 7.30 7.35 6.92 7.13 7.13 462,049
Dec 18, 2025 7.55 7.56 7.18 7.35 7.35 93,711
Dec 17, 2025 7.55 7.70 7.34 7.41 7.41 74,780
Dec 16, 2025 7.59 7.61 7.36 7.58 7.58 78,393
Dec 15, 2025 7.77 7.88 7.47 7.54 7.54 59,715
Dec 12, 2025 7.90 8.09 7.67 7.69 7.69 73,849
Dec 11, 2025 8.38 8.38 7.80 7.87 7.87 54,278
Dec 10, 2025 7.92 8.50 7.92 8.46 8.46 134,193
Dec 9, 2025 8.12 8.15 7.96 8.04 8.04 56,583
Dec 8, 2025 7.97 8.20 7.78 8.16 8.16 126,010
Dec 5, 2025 7.90 8.03 7.76 7.98 7.98 76,969
Dec 4, 2025 7.64 7.90 7.50 7.90 7.90 45,942
Dec 3, 2025 7.50 7.67 7.36 7.64 7.64 67,457
Dec 2, 2025 7.59 7.76 7.56 7.58 7.58 37,753
Dec 1, 2025 7.80 7.83 7.58 7.67 7.67 53,184
Nov 28, 2025 7.89 7.89 7.66 7.75 7.75 26,672
Nov 26, 2025 7.67 7.95 7.67 7.85 7.85 60,112
Nov 25, 2025 7.75 7.94 7.62 7.72 7.72 42,335
Nov 24, 2025 7.53 7.96 7.46 7.87 7.87 62,052
Nov 21, 2025 7.42 7.66 7.39 7.55 7.55 47,506
Nov 20, 2025 7.53 7.81 7.44 7.49 7.49 39,777
Nov 19, 2025 7.61 7.67 7.43 7.57 7.57 41,648
Nov 18, 2025 7.95 7.95 7.57 7.67 7.67 58,356
Nov 17, 2025 7.95 8.47 7.90 8.02 8.02 102,731
Nov 14, 2025 7.94 8.22 7.82 7.99 7.99 64,149
Nov 13, 2025 8.14 8.32 7.97 8.08 8.08 52,997
Nov 12, 2025 8.00 8.38 7.75 8.34 8.34 70,015
Nov 11, 2025 7.78 8.09 7.75 8.01 8.01 49,416
Nov 10, 2025 7.63 8.04 7.45 7.92 7.92 80,550
Nov 7, 2025 7.27 7.30 7.12 7.21 7.21 47,516
Nov 6, 2025 7.39 7.43 7.25 7.34 7.34 42,127
Nov 5, 2025 7.30 7.41 7.21 7.39 7.39 48,910
Nov 4, 2025 7.47 7.47 7.25 7.25 7.25 64,193
Nov 3, 2025 7.79 7.79 7.26 7.36 7.36 42,745
Oct 31, 2025 7.61 7.79 7.55 7.75 7.75 36,237
Oct 30, 2025 7.61 7.76 7.45 7.65 7.65 46,529
Oct 29, 2025 7.73 7.96 7.48 7.54 7.54 53,139
Oct 28, 2025 7.97 8.01 7.71 7.74 7.74 41,049
Oct 27, 2025 8.26 8.37 7.97 8.02 8.02 69,856
Oct 24, 2025 8.35 8.35 8.11 8.17 8.17 43,970
Oct 23, 2025 8.01 8.31 7.96 8.23 8.23 141,171
Oct 22, 2025 8.27 8.37 7.75 7.89 7.89 109,195
Oct 21, 2025 8.30 8.45 8.24 8.32 8.32 39,244
Oct 20, 2025 8.35 8.43 8.21 8.34 8.34 31,487
Oct 17, 2025 8.57 8.88 8.16 8.30 8.30 70,929
Oct 16, 2025 9.00 9.42 8.70 8.74 8.74 128,688
Oct 15, 2025 8.30 8.99 8.30 8.87 8.87 177,116
Oct 14, 2025 8.29 8.39 7.98 8.01 8.01 67,677
Oct 13, 2025 8.09 8.42 8.09 8.39 8.39 91,332
Oct 10, 2025 7.75 8.50 7.75 7.96 7.96 331,186
Oct 9, 2025 7.20 7.43 7.15 7.15 7.15 87,962
Oct 8, 2025 7.29 7.44 7.25 7.30 7.30 43,759
Oct 7, 2025 7.36 7.36 7.25 7.27 7.27 48,006
Oct 6, 2025 7.36 7.39 7.20 7.34 7.34 81,679
Oct 3, 2025 7.60 7.72 7.35 7.41 7.41 57,078
Oct 2, 2025 7.55 7.61 7.48 7.52 7.52 54,328
Oct 1, 2025 7.36 7.78 7.29 7.58 7.58 74,377
Sep 30, 2025 7.46 7.50 7.20 7.46 7.46 72,804
Sep 29, 2025 7.30 7.54 7.24 7.50 7.50 48,454
Sep 26, 2025 7.39 7.46 7.15 7.16 7.16 55,640
Sep 25, 2025 7.31 7.37 7.13 7.29 7.29 45,770
Sep 24, 2025 7.28 7.48 7.28 7.37 7.37 30,068

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Gyre Therapeutics, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at GYRE, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation